Related Experiment Video

Updated: Aug 9, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases

Christian Hildmann1, Dennis Wegener, Daniel Riester

  • 1Department of Molecular Genetics and Preparative Molecular Biology Institute for Microbiology und Genetics, Goettingen, Germany.

Journal of Biotechnology
|March 29, 2006
PubMed

Insights

Histone deacetylases (HDACs) are crucial for gene expression and cancer therapy. This study compares class 1 HDACs and a bacterial homologue, identifying structural differences for developing targeted anticancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Histone deacetylases (HDACs) regulate gene expression in eukaryotes.
  • HDACs are emerging as significant targets for anticancer therapies.
  • HDACs are classified into four groups: classes 1-4.

Purpose of the Study:

  • To compare class 1 HDACs with FB188 HDAH, a bacterial homologue of HDAC6 (class 2).
  • To investigate differences in substrate and inhibitor specificity.
  • To identify structural regions responsible for specificity differences.

Main Methods:

  • Comparative analysis of class 1 HDACs and FB188 HDAH.
  • Substrate and inhibitor specificity assays.
  • Structural comparison to pinpoint specificity determinants.

Main Results:

  • Detailed comparison of class 1 HDACs and FB188 HDAH revealed distinct substrate and inhibitor specificities.
  • Structural analysis identified specific regions correlating with these observed differences.
  • This provides a basis for understanding HDAC subtype biochemical roles.

Conclusions:

  • Structural insights into HDAC specificity can guide the development of selective HDAC inhibitors.
  • Targeted HDAC inhibitors hold promise as novel antitumor agents.
  • Understanding structural variations is key for advancing HDAC-targeted cancer therapy.

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Single-Step Enrichment of a TAP-Tagged Histone Deacetylase of the Filamentous Fungus Aspergillus nidulans for Enzymatic Activity Assay09:07

Single-Step Enrichment of a TAP-Tagged Histone Deacetylase of the Filamentous Fungus Aspergillus nidulans for Enzymatic Activity Assay

Published on: May 1, 2019

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...